Skip to main content

Table 3 Association between KDM2A mRNA expression and clinical features in ccRCC

From: Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma

Parameters n KDM2A mRNA expression in ccRCC P
Low, n (%) High, n (%)
Gender     
Male 29 12 (41.4%) 17 (58.6%) 0.152
Female 21 13 (61.9%) 8 (38.1%)  
Age, years     
< 60 28 13 (46.4%) 15 (53.6%) 0.569
≥ 60 22 12 (54.5%) 10(45.5%)  
Location     
Left 22 12 (54.5%) 10 (45.5%) 0.569
Right 28 13 (46.4%) 15 (53.6%)  
BMI (kg/m2)     
< 24 20 7 (35.0%) 13 (65.0%) 0.083
≥ 24 30 18(60.0%) 12 (40.0%)  
Tumor size (cm)     
≤ 7 35 22 (62.9%) 13(37.1%) 0.005
> 7 15 3 (20.0%) 12 (80.0%)  
Smoking     
No 39 20 (51.3%) 19 (48.7%) 0.733
Yes 11 5 (45.5%) 6 (54.5%)  
Thrombus of renal vein     
No 46 24 (52.2%) 22 (47.8%) 0.602
Yes 4 1 (25.0%) 3 (75.0%)  
TNM stage     
T1–T2 38 22 (57.9%) 16 (42.1%) 0.047
T3–T4 12 3 (25.0%) 9 (75.0%)  
ISUP grade     
1–2 35 19(54.3%) 16 (45.7%) 0.355
3–4 15 6 (40.0%) 9 (60.0%)  
Symptoms     
No 32 15 (46.9%) 17 (53.1%) 0.556
Yes 18 10 (55.6%) 8 (44.4%)  
Hypertension     
No 29 16 (55.2%) 13 (44.8%) 0.390
Yes 21 9 (42.9%) 12 (57.1%)